IP & Assets

Legit.Health's intellectual property portfolio spans trademarks, patents, industrial design, proprietary algorithms, and domain assets. This page reflects the current status as of May 2026.

2

Trademarks registered

4

TM applications pending

3

Patent applications

59

Proprietary AI models

Trademarks

The "Legit.Health" figurative mark is protected across all key commercial markets through a structured international strategy.

🇪🇺

European Union

EUIPO — figurative mark "Legit.Health" covers all 27 EU Member States

✅ Registered

🇭🇰

Hong Kong

Figurative mark "Legit.Health" registered

✅ Registered

🌍

Madrid System (WIPO)

International registration via Madrid Protocol, using EU mark as base. Cost-efficient expansion mechanism.

🔄 Filed

🇺🇸

United States (USPTO)

Application under examination. Active office action being addressed; no material issues expected.

🔄 Under examination

🇧🇷

Brazil

Application filed in anticipation of LATAM commercial expansion (ANVISA medical device already registered Q1 2025).

🔄 Under examination

🇬🇧

United Kingdom

Application filed in anticipation of UK commercial expansion (UKCA Class IIa medical device already registered 2024).

🔄 Under examination

A global trademark watch service is in place, actively monitoring new filings worldwide to identify potential infringements or conflicting marks at an early stage.

Patents

Skin image calibration AI

A patent covers Legit.Health's core AI-based technology for the automated calibration of digital skin images, used to assist in measuring severity of skin conditions. Applications are under examination in two jurisdictions:

European Patent Office (EPO)

Application published, under substantive examination. EPO raised objections on priority, novelty, and inventive step. Patent counsel responding within deadline; objections expected to be addressed through claim amendments.

🔄 Under examination

United States (USPTO)

Application published, currently under examination.

🔄 Under examination

Co-patent with Pierre Fabre Dermo-Cosmétique (50%)

🤝

Pierre Fabre Dermo-Cosmétique

50/50 co-applicant · October 2024

Legit.Health is a 50% co-applicant on a patent family protecting a predictive algorithm, co-developed with Pierre Fabre Dermo-Cosmétique (a major French pharmaceutical and dermo-cosmetics group). The family covers two pending applications for the same invention: a European patent application (EP23306096.1) before the EPO, and a French patent application before the INPI.

Key terms of the co-ownership (investor-relevant):

Free commercial exploitation

Both co-owners can exploit the invention freely and independently, including in medical devices, without owing royalties or requiring consent from the other party (Article 11).

Pierre Fabre bears all costs

Pierre Fabre bears the full cost of filing, prosecution, maintenance, and defence of the patent family.

Automatic transfer if abandoned

Should Pierre Fabre cease to fund or abandon the patents, its 50% share transfers automatically and irrevocably to Legit.Health at no cost.

Why this matters

Pierre Fabre independently decided this algorithm was valuable enough to co-file a patent and fund 100% of prosecution costs. This is external pharma validation of Legit.Health's algorithmic capabilities — not a commercial agreement but an IP co-creation that aligns incentives long-term.

Industrial design

Legit.Health holds a Registered Community Design (RCD) at the European Union Intellectual Property Office (EUIPO), protecting the visual appearance of its clinical user interface across all 27 EU Member States.

EUIPO Registered Community Design

Clinical user interface visual appearance · Protected across 27 EU Member States

✅ Registered · Application ongoing in the US

Proprietary algorithms

Beyond the patent portfolio, Legit.Health maintains 59 proprietary AI models protected as trade secrets and under copyright law. These include clinical scoring algorithms, image processing pipelines, and machine learning models developed entirely in-house.

See the full AI algorithms catalogue → for a breakdown by category.

Protection layers:

Copyright over source code

All models and pipelines are original works protected by copyright from their creation.

Trade secret protections

Core competitive advantages not disclosed through the patent system are maintained as trade secrets.

Employment & contractor agreements

Confidentiality obligations embedded in all employment and contractor agreements.

Technical access controls

Architectural and infrastructure controls limit access to model weights, training data, and annotation pipelines.

On algorithm patentability in Europe

Deep learning models are generally not patentable under European patent law (EPC Article 52 excludes "mathematical methods" and "programs for computers" as such). The correct protection strategy in Europe is copyright + trade secrets, which is what Legit.Health applies. The calibration patent is a specific technical method, not the algorithm itself.

Registered domains

legit.healthlegithealth.usaimarkers.comaprenderma.comaprenderma.orgclinimage.co.ukclinimage.appclinimage.euclinimage.devitiligo.appwonderma.proskinreveal.appescaneatupiel.es

13 domains registered, covering the core brand and strategic verticals (wound care, vitiligo, acne, dermo).